background image

Paid Clinical Trials California

Discover 5,180 paid clinical trials in California. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Redwood City, Salt Lake City, Seattle, Dallasshow 7 more

Code:

NCT04064827

Conditions

Chronic Kidney Disease (CKD)

Secondary Hyperparathyroidism (SHPT)

Eligibility Criteria

Sex: All

Age: 0 - 9

Healthy Volunteers: Not accepted

Interventions

Paricalcitol

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

Recruiting

Sponsor:

Leigh R. Hochberg, MD, PhD.

Location:

Stanford, Boston

Code:

NCT05724173

Conditions

Anarthria

Dysarthria

Tetraplegia

Spinal Cord Injuries

Amyotrophic Lateral Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BrainGate Neural Interface System

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

Recruiting

Sponsor:

Edwards Lifesciences

Location:

Stanford, San Francisco, Newport Beach, Seattleshow 25 more

Code:

NCT05172973

Conditions

Aortic Valve Insufficiency

Aortic Valve Stenosis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

SAPIEN X4 THV

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

Recruiting
PHASE1
PHASE2

Sponsor:

Takeda

Location:

San Francisco, Seattle, Aurora, Sioux Fallsshow 7 more

Code:

NCT04844073

Conditions

Squamous Cell Cancer of Head and Neck (SCCHN)

Non-small Cell Lung Cancer (NSCLC)

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAK-186

A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06)

Recruiting
PHASE2
PHASE3

Sponsor:

ALX Oncology Inc.

Location:

Los Angeles, Anaheim, Seattle, Nashvilleshow 1 more

Code:

NCT05002127

Conditions

Gastric Cancer

Gastroesophageal Junction Adenocarcinoma

Gastric Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evorpacept (ALX148)

Trastuzumab

Ramucirumab

Paclitaxel

Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia

Recruiting

Sponsor:

Stanford University

Location:

Palo Alto

Code:

NCT04885127

Conditions

Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Palliative Care + Digital Symptom Monitoring

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Recruiting
PHASE2

Sponsor:

Gilead Sciences

Location:

San Francisco, Los Angeles, Salt Lake City, Tucsonshow 31 more

Code:

NCT03547973

Conditions

Metastatic Urothelial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab Govitecan-hziy

Pembrolizumab

Cisplatin

Avelumab

Zimberelimab

Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

Recruiting
PHASE2

Sponsor:

Joseph Tuscano

Location:

Fresno, Sacramento, Los Angeles, San Diego

Code:

NCT04450173

Conditions

Ann Arbor Stage II Follicular Lymphoma

Ann Arbor Stage III Follicular Lymphoma

Ann Arbor Stage IV Follicular Lymphoma

Grade 1 Follicular Lymphoma

Grade 2 Follicular Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ibrutinib

Obinutuzumab

Venetoclax

CD19-Car T Cell Therapy for the Treatment of Older Adults With Acute Lymphoblastic Leukemia in First Remission

Recruiting
PHASE1

Sponsor:

City of Hope Medical Center

Location:

Duarte

Code:

NCT05707273

Conditions

B Acute Lymphoblastic Leukemia

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Autologous Anti-CD19 CAR-expressing T Lymphocytes

Biospecimen Collection

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Fludarabine

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Recruiting

Sponsor:

American Thrombosis and Hemostasis Network

Location:

Sacramento, Los Angeles, Phoenix, Oklahoma Cityshow 19 more

Code:

NCT04647227

Conditions

Hemophilia A With Inhibitor

Hemophilia B With Inhibitor

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

coagulation factor VIIa [recombinant]-jncw

Popular cities in California

With its extensive healthcare system and world-class medical research institutions, California is a major hub for clinical trials. Leading research centers such as UCLA Health, Stanford Medicine, the University of California, the City of Hope, San Francisco (UCSF), and the Scripps Research Institute are spearheading medical research and innovation. These institutions are at the cutting edge of clinical studies, driving advancements in groundbreaking treatments and significantly contributing to healthcare innovations across the state.

Why choose California for clinical trials?

Common conditions studied in California

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in California